Samuel Strauch, CEO Of Metrik Holdings

Samuel Strauch, CEO of Metrik Holdings is a successful real estate broker located in Miami, Florida. He had a vision a little over a decade ago to build his real estate firm because the Latin America community was growing. He started out by connecting with his friends and family who were interested in buying or selling real estate. Since then, he has become a well-known realtor in his community.

Samuel Strauch is a man who keeps an open mind and adapts to new environments accordingly. He is the epitome of change and understands the importance of staying updated with current market trends. His current focus is finding real estate that can assist the millennials. In a recent interview, he stated “very rapid changes in the way that people live, works and in the way people travel.” (ceoofinterviews.com). Successful business owners put customers first by satisfying their needs and wants.

Samuel Strauch is a trusted source in the Latin America community. His real estate practice caters to each customer based on their personal needs and wants. His company has built a strong reputation with customers referring others. People are looking for a realtor who is trustworthy and have what they need. New customers have also found his company from successful marketing tactics. Samuel Strauch graduated with a business degree so that explains where some of his success strategies come from. He took it to another level by investing in “several other internet and restaurant businesses.” (crunchbase.com). The world will soon know about Mr. Strauch and his quality business actions.

Read more on Medium.com.

Clay Siegall – Leader of a Large Medical Research Company

Clay Siegall, Ph. D. is the founder of a leading company dedicated to medical research – Seattle Genetics. He worked for about a decade at the Bristol – Myers Squibb Pharmaceutical Research Institute before he moved on to take a position at the National Cancer Institute. Dr Clay Siagall founded his company Seattle Genetics in 1988. He works as the President and Chief Executive Officer of the esteemed company.

Seattle Genetics developed a medication which was approved by the U. S. Food and Drugs Association in 2011. The first ADC is now available on the drug market in more than seventy countries all around the world. Clay Siegall, Ph. D. is the owner of more than ten patents, and some of them have been launched on the market and have been made widely available to the public.

Clay Siegall, Ph. D. decided to establish his company Seattle Genetics because he wanted to contribute as much as possible could to the research against cancer. He views the medical science of oncology as one of the most crucial ones in the world of medicine. Cancer, however, has many types and some of them have been studied too little. There is nowhere near enough data collected of breast cancer, for example. Clay Siegall, Ph. D. wanted to improve the tools that were already available to oncologists both for research purposes and for treating the patients.

Clay Siegall, Ph. D. is the author of more than seventy articles on the topics of medicine, research against cancer, and the process of establishing a company. His advice to young entrepreneurs is to learn as much as possible. He advises them to never pass up on an opportunity to learn from those who are more experienced than they are because the key to success is closely related to knowing your field well enough.

Seattle Genetics and Dr Clay Siegall have made great contributions to the medical field. Dr Clay Siegall has also done philanthropy work, and he also doubles as a teacher at a university. He has given a large number of seminars and has spoken at many medical events all around the world.